110 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
25 Mar 24
Results of Operations and Financial Condition
7:03am
reimbursement from TOI. Further, we anticipate G&A expenses to remain relatively flat for the year. We believe this balances our
desire … , and commercial milestones; tiered royalties of up to low 20’s on net sales; and reimbursement of KIO-301 research and development expenses.
Completed
8-K
EX-10.2
bsee95oddd
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
zuh7cdu
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-99.1
4o8vmx61 i0oaowed9
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-10.1
mufwrnqcpok2 fko40
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-4.3
9wz65zvf 8gpl71zz
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-1.1
2jj0i1m
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
424B1
t6ytblb0c6 b7l8um
2 Jun 23
Prospectus with pricing info
5:08pm